Strangvac, a vaccine against equine strangles, has been granted marketing authorisation in the UK
Stockholm, September 17, 2021 - Intervacc AB (“Intervacc”) announced today that the Veterinary Medicines Directorate (VMD) of the United Kingdom has granted a Marketing Authorisation for Strangvac within the UK. Strangvac is a vaccine against equine strangles, a highly contagious infectious disease that affects horses globally.
“We are delighted that Strangvac has been granted a market authorisation in the UK” explained Andreas Andersson, CEO of Intervacc. “Up to 600 outbreaks of strangles occur in the UK each year, impacting thousands of horses and we feel a great responsibility to